Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status

Overview

About this study

Do ambulatory RBC transfusions improve home functional status?

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age > 18 years
  • At least on prior encounter in the ambulatory infusion center
  • Planned RBC transfusion

Exclusion Criteria:

  • Refusal to provide informed consent
  • Refusal by the health care team
  • Acute ischemia (e.g. MI, CVA)
  • Hemoglobin < 7.0 g/dL
  • Active bleeding
  • Symptomatic anemia (hypotension, tachycardia, angina, syncope/pre-syncope believed related to anemia
  • Non-ambulatory functional status
  • Established or Uncertain Pregnancy Status

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Daryl Kor, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions